DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/85wvzp/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring System 2014 - 2020" report to their offering.
Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from Finger based self-monitoring blood glucose devices. SMBG devices are cheaper and easy to use and are easily approved by the authorities. SMBG has more number of players and larger market share.
However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. . CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for pediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers.
Global Continuous Glucose Monitoring System Market
- CGM Market
- Real Time Monitoring
- Integrated Insulin Pumps
- Blood Glucose
- Global Health
- IPRO Glucose
- Growing Diabetic Population
- Type 1 & 2 Diabetes
- Nocturnal Hypoglycemia
Key Topics Covered:
Chapter 1. Executive Summary
Chapter 2. Market Overview
Chapter 3. Market Determinants
Chapter 4. Sector Analysis: Diabetes Care
Chapter 5. Cgms Market By Devices
Chapter 6. By Application
Chapter 7. Competitive Intelligence
Chapter 8. Market Share Analysis
Chapter 9. Geographical Analysis
Chapter 10. Corporate Profile: Benchmark Study
- Medtronic Inc.
- Johnson And Johnson (J&J) (Animas Corp)
- Insulet Corp
- Tandem Diabetes
- Echo Therapeutics
For more information visit http://www.researchandmarkets.com/research/85wvzp/global_continuous